nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—SLC22A11—Methotrexate—lymphatic system cancer	0.337	0.337	CbGbCtD
Piroxicam—CYP2C9—Teniposide—lymphatic system cancer	0.215	0.215	CbGbCtD
Piroxicam—SLC22A8—Methotrexate—lymphatic system cancer	0.196	0.196	CbGbCtD
Piroxicam—SLC22A6—Methotrexate—lymphatic system cancer	0.136	0.136	CbGbCtD
Piroxicam—ALB—Methotrexate—lymphatic system cancer	0.116	0.116	CbGbCtD
